CIENCIASMEDICASNEWS: BioEdge: Deliberately infecting healthy patients still happens

sábado, 28 de mayo de 2016

BioEdge: Deliberately infecting healthy patients still happens—ethically

Deliberately infecting healthy patients still happens—ethically

by Michael Cook | 28 May 2016 | Link

The most famous clinical trial of all time was Edward Jenner’s experiment with a smallpox vaccine. He had a hunch that exposure to cowpox would protect humans against smallpox. So he immunised James Phipps, the son of his gardener, and then deliberately infected him with smallpox after six weeks and later on as well, another 20 times. “Poor Phipps” did not die, at least not of smallpox, and his cooperation saved hundreds of millions of lives.

This is a milestone in modern medicine, but Jenner’s experiment would not pass an ethics review nowadays. For one thing, Phipps hardly gave his informed consent. However, unknown to most people, Jenner’s methodology is still used. Healthy people are being infected and observed to see whether they become ill (or die). Nowadays the technique is called a Human Challenge Study (HCS).

An article this week in Science profiled some of the leading figures in HCS in the United States. Volunteers are being deliberately infected with infected with malaria, influenza, shigella, dengue, norovirus, tuberculosis, rhinovirus, Escherichia coli, typhoid, giardia, and campylobacter. Researchers try to make the virus as attenuated as possible to minimise the danger and then treat the illness as quickly and effectively as possible.

In many ways HCS is better than standard clinical trials. It is faster, cheaper and can give useful information about potential side effects of treatments.

HCS have been in a bad odour for decades, largely because of Nazi experiments on prisoners in concentration camps. The world was outraged and some of the doctors were hanged, but in the US similar experiments were carried out on prisoners, without their consent. However, researchers like Levine insist that well-regulated, ethical HCS is possible – and is desperately needed.

What about volunteers? Astonishingly HCS researchers do not find it difficult to recruit subjects even for exotic diseases like cholera or dengue fever.

At least one company specialises in conducting HCS trials, hVIVO, a London-based firm. Its “Flu Camp” website tells potential volunteers that they can earn up to £3,450 Pounds by working 10 to 14 days and living in a quarantined hotel.

- See more at: http://www.bioedge.org/bioethics/deliberately-infecting-healthy-patients-still-happensethically/11895#sthash.QAPpzfCy.dpuf

We want to send a big thank-you to everyone who contributed to BioEdge over the past four weeks. Our goal for annual donations this year was US$15,000 – and we received just about half of this during May. We’re more or less on target.

This is very encouraging for our work in reporting on significant developments in bioethics around the world.

We know that we can do better. Occasionally there are glitches and omissions. We always appreciate your suggestions and, sometimes, your admonishments!

This year we hope use social media more effectively to draw readers to the site. But the best way of attracting new subscribers is by word of mouth. Please encourage your friends and colleagues to sign up!

If you meant to give a donation, but it slipped your mind, there’s still time before the end of the month. Here’s the link:
http://www.bioedge.org/supportbioedge

Thanks again.

Michael Cook
Editor